A survey on the factors causing delayed diagnosis and treatment of breast cancer in southeastern Anatolia

Yıl 2015, Cilt: 6 Sayı: 4, 375 - 381, 03.01.2016

Eyüp Öner Sadullah Girgin Ömer Uslukaya Zübeyir Bozdağ Hatice Gümüş Zuhat Urakçı Metehan Gümüş

https://doi.org/10.5799/ahinjs.01.2015.04.0552

Öz

Objective: This survey aims to elucidate patient and health system related factors leading to delayed diagnosis and treatment of breast cancer in Southeastern Anatolia.

Methods: Hundred patients admitted to Department of General Surgery at Dicle University between December 2012 and July 2014, and diagnosed with breast cancer in preceding 6 months were included in the survey after their consent. The survey has 4 chapters (patient and health system related factors, demographic data, and assessment of cancer stage) and 25 questions.

Results: Fifty-eight percent of patients visited a physician with a 3 months delay after realization of breast cancer symptoms. Only 8% of patients had regular check-ups. Nine percent of patients were suspicious of breast cancer due to the lesion in the breast. 86% of patients did not consider it to be a serious matter. Lack of female physicians cited by 2% as the reason for avoiding doctor’s visit. Seven percent cited lack of knowledge and 23% being scared. Seventy-seven percent were able to get a doctor’s appointment, 82% to get mammography, 78% underwent biopsy in a week. Women between the ages of 30-50 had higher concern about cancer (p<0.05). Women who were illiterate or housewives regarded doctor’s visitation as not a good experience (p<0.05).

Conclusion: Patients’ age and literacy, and efficiency of health system may be contributing factors on the delay of diagnosis and treatment of breast cancer. Cancer awareness should be increased and fear being diagnosed with cancer should be overcome in women between the ages of 30-50 to decrease the delay of diagnoses. J Clin Exp Invest 2015; 6 (4): 375-381

Key words: Breast cancer, delay on diagnosis and treatment, a survey

Anahtar Kelimeler

Meme kanseri, tanı ve tedavide gecikme, anket

Kaynakça

• Surveillance, Epidemiology, and Results (SEER). Program (www.seer.cancer.gov): SEER Stat Database: IncidenceSEER 9 Regs Public Use, Nov 2005 Sub (1973-2003). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
• Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792.
• Shetty MK, Longatto-Filho A. Early detection of breast, cervical,
• ovarian and endometrial cancers in low resource contries: an integrated approach. Indian J Surg Oncol 2011;2:165-171.
• Dundar PE, Ozmen D, Ozturk B, et al. The knowledge and attitudes of breast self-examination and mammography in a group of women in rural area in western Turkey. BMC Cancer 2006;6:43.
• Saip P, Keskin S, Ozkan M,et al. The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational study. J BUON 2011;16:664-671.
• Ozmen V, Ozaydin N, Cabioglu N, et al. Survey on a ammographic
• screening program in Istanbul Turkey. Breast J 2011;17:260-267.
• Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol 2013:20;2468-2476.
• Rutqvist LE. Waiting times for cancer patients--a “slippery slope” in oncology. Acta Oncol 2006;45:121-123.
• Richards MA. The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Cancer 2009:3;101 Suppl 2:S1-4.
• Partridge AH, Hughes ME, Ottesen RA, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 2012;17:775-782.
• Sikora K. Genes, dreams, and cancer. MJ 1994:7;1217-1221.
• Ozmen V, Boylu S, Ok E, et al. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015;25:9-14.
• Fedewa SA, Edge SB, Stewart AK, et al. Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). J Health Care Poor Underserved 2011;22:128-141.
• Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011;11:284.
• Otieno ES, Micheni JN, Kimende SK, Mutai KK. Provider delay in the diagnosis and initiation of definitive treatment for breast cancer patients. East Afr Med J 2010;87:143-146.
• Norsa’adah B, Rampal KG, Rahmah MA, et al. Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer 2011;11:141-146.
• Chintamani, Tuteja A, Khandelwal R, et al. Patient and provider delays in breast cancer patients attending a tertiary care centre: a prospective study. JRSM Short Rep 2011;2:76-82.
• Jassem J, Bacanu F, Eglitis J, et al. Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AVM): An international survey. J Clin Oncol 2012; 30, (suppl; abstr 9046).
• Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005;92:1959–1970.
• Jassem J, Ozmen V, Bacanu F, et al. Factors influencing time to seeking medical advice and start of treatment in breast cancer – an international survey. Thirty-fifth Annual CTRC-AACR San Antonio Breast Cancer Symposium –December 4-8, 2012; San Antonio, TX (abstract).
• Montella M, Crispo A, D’Aiuto G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001;10:53-59.
• Rauscher GH, Ferrans CE, Kaiser K, et al. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev 2010;19:640-647.
• Robertson R, Campbell NC, Smith S, et al. Factors influencing
• time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 2004;90:1479-1485.
• Yau TK, Choi CW, Ng E, et al. Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre. Hong Kong Med J 2010;16:373-377.
• Hofvind S, Lee CI, Elmore JG. Stage-specific breast cancer
• incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 2012;135:291-299.
• Kayhan A, Gurdal SO, Ozaydin N, et al. First round results of a long term population-based breast cancer screening program from Bahçesehir. J Breast Health 2012; 8:180-184.
• Fornier MN, Modi S, Panageas KS, Norton L. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005;104:1575-1579.
• Online: Türkiye İstatistik Kurumu (Turkish Statistical Institute).
• Available at http://www.tuik.gov.tr [accessed: July 2013].
• Jensen LF, Pedersen AF, Andersen B, Vedsted P. Identifying
• specific non-attending groups in breast cancer screening population-based registry study of participation and socio-demography. BMC Cancer 2012;12:518-522.